Evidence map›Paper›PMID 38126784›Full record

ArticlemBio2024

Spatial and temporal control of lysis by the lambda holin.

Jesse Cahill, Ashley Holt, Matthew Theodore, Russell Moreland, Chandler O'Leary, Cody Martin, Kelsey Bettridge, Jie Xiao, Ry Young

Abstract read
In one paragraph

Article in mBio, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. The Lysis cassette of jumbophage PhiKZ.Scientific reports · 2026
    Article
  4. Article
  5. Review
  6. The Lysis Cassette of Jumbophage phiKZ.bioRxiv : the preprint server for biology · 2025
    Article
  7. Article
  8. A Novel LyticFoods (Basel, Switzerland) · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jesse CahillSandia National Labs, Albuquerque, New Mexico, USA.ORCID 0000-0001-8387-9273
Ashley HoltDepartment of Biochemistry and Biophysics, Center of Phage Technology, Texas A&M University, College Station, Texas, USA.ORCID 0000-0002-6365-7144
Matthew TheodoreDepartment of Biochemistry and Biophysics, Center of Phage Technology, Texas A&M University, College Station, Texas, USA.
Russell MorelandDepartment of Biochemistry and Biophysics, Center of Phage Technology, Texas A&M University, College Station, Texas, USA.
Chandler O'LearyDepartment of Biochemistry and Biophysics, Center of Phage Technology, Texas A&M University, College Station, Texas, USA.
Cody MartinDepartment of Biochemistry and Biophysics, Center of Phage Technology, Texas A&M University, College Station, Texas, USA.
Kelsey BettridgeDepartment of Biophysics and Biophysical Chemistry, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Jie XiaoDepartment of Biophysics and Biophysical Chemistry, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Ry YoungSandia National Labs, Albuquerque, New Mexico, USA.ORCID 0000-0001-8001-2914

Funding

PROGRAM IN MOLECULAR BIOPHYSICST32GM008403 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI BARRICK, DOUGLAS E. · 1990 to 2019
$13.5M
Spatial Organization and Regulation of Bacterial Cellular ProcessesR35GM136436 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI Jie Xiao · 2020 to 2026
$4.8M
CONTROL OF VIRUS-INDUCED LYSISR01GM027099 · NIGMS · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI YOUNG, RYLAND FLETCHER · 1985 to 2019
$4.6M
Phage LysisR35GM136396 · NIGMS · TEXAS A&M AGRILIFE RESEARCH · PI YOUNG, RYLAND FLETCHER · 2020 to 2024
$1.9M
Design of hetero-multivalent targeted liposome for combating intracellular Mycobacterium tuberculosisR21AI149383 · NIAID · TEXAS ENGINEERING EXPERIMENT STATION · PI CIRILLO, JEFFREY D., WU, HUNG-JEN · 2020 to 2021
$416k
NIAID NIH HHS R21 AI149383NIGMS NIH HHS R01 GM027099NIGMS NIH HHS R35 GM136396NIGMS NIH HHS R35 GM136436
6 · The paper itself

Abstract

The infection cycle of phage λ terminates in lysis mediated by three types of lysis proteins, each disrupting a layer in the bacterial envelope: the S105 holin, the R endolysin, and the Rz/Rz1 spanin complex targeting the inner membrane, cell wall or peptidoglycan, and the outer membrane, respectively. Video microscopy has shown that in most infections, lysis occurs as a sudden, explosive event at a cell pole, such that the initial product is a less refractile ghost that retains rod-shaped morphology. Here, we investigate the molecular basis of polar lysis using time-lapse fluorescence microscopy. The results indicate that the holin determines the morphology of lysis by suddenly forming two-dimensional rafts at the poles about 100 s prior to lysis. Given the physiological and biochemical similarities between the lambda holin and other class I holins, dynamic redistribution and sudden concentration may be common features of holins, probably reflecting the fitness advantage of all-or-nothing lysis regulation.IMPORTANCEIn this study, we use fluorescent video microscopy to track -green fluorescent protein (GFP)-labeled holin in the minutes prior to phage lysis. Our work contextualizes prior genetic and biochemical data, showing when hole formation starts and where holin oligomers form in relation to the site of lytic rupture. Furthermore, prior work showed that the morphology of lambda-infected cells is characterized by an explosive event starting at the cell pole; however, the basis for this was not clear. This study shows that holin most often oligomerizes at cell poles and that the site of the oligomerization is spatially correlated with the site of lytic blowout. Therefore, the holin is the key contributor to polar lysis morphology for phage lambda.

Indexed as

Bacteriophage lambdaViral ProteinsBacteriolysisCell DeathCell WallViral Proteinsholeslysismorphologyplasmolysispolarraftsthioflavin-T

Identifiers

PMID38126784
PMCPMC10865782

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.